Dane Chetkovich

July 11, 2022

A speedier treatment for depression?

Vanderbilt researchers used a computer-based search to identify a compound with promise as a new, mechanistically distinct and rapid-acting therapy for major depressive disorder.

By Paul Govern
Research by Dane Chetkovich, MD, PhD, right, Ye Han, PhD, and colleagues on how antidepressants work points to possible new targets for drug development.
December 1, 2021

Study provides new insight into how antidepressant drugs work

A study by Vanderbilt researchers sheds light on how current antidepressant drugs work and suggests a new drug target in depression.

By Paul Govern
Evan Campa and Eben Cathey, along with their children, Mae and Reuben, are helping to raise funds to create an ALS research program at VUMC.
September 23, 2021

Local family shines in campaign to establish ALS research program

Evan Campa and her family are at the forefront of a campaign to establish an ALS basic science research program at Vanderbilt.

By Paul Govern
December 12, 2019

A new anti-seizure target?

Vanderbilt neurologists have identified a protein modification that could be targeted to reduce neuronal excitability in epilepsy.

By Leigh MacMillan
L-r: Eric Johnson, Björn Knollmann, Dai Chung, Dan Roden, Russell Rothman, Susan Wente, Carrie Kitko, Dane Chetkovich, Rangaraj Ramanujam, Timothy Vogus, Berk Sensoy and Jeff Balser. (John Russell/Vanderbilt)
March 5, 2018

Nine new endowed chair recipients honored

Nine Vanderbilt University faculty members named to endowed chairs were honored during a celebration at the Student Life Center Feb. 28.

By VUMC News and Communications
May 26, 2017

Chetkovich named chair of Department of Neurology

Dane Chetkovich, M.D., Ph.D., professor of Neurology and Physiology and director of the Medical Scientist Training Program at Northwestern University Feinberg School of Medicine in Chicago, has been named chair of Vanderbilt’s Department of Neurology. He will join the faculty on Sept. 1.

By Nancy Humphrey